A study of Kodiveli chooranam in the management of Hyperhomocysteinemia in Stroke syndrome patients(Patchavatham)

Effectiveness of Kodiveli chooranam in the management of Hyperhomocysteinemia in Stroke syndrome patients (Patchavatham) among out patients attending Ayothidoss Pandithar Hospital, National Institute of Siddha-clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049709

Enrollment

Registered

2023-02-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

Intervention1: Kodiveli Chooranam: 1g bd with hotwater Intervention2: kodiveli chooranam: 1gm twice a day with hot water for 48 days Control Intervention1: NIL: NIL Control Intervention2: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Homocysteine >10mcmol

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Known hypersensitivity or allergy to drug ingredients. End organ failure Haemorrhagic stroke

Design outcomes

Primary

Measure	Time frame
Changes in the homocysteine levels from the baseline at 48th day will be assessedTimepoint: Changes in the homocysteine levels from the baseline at 48th day will be assessed	—

Secondary

Measure	Time frame
Changes in quality of life will be assessed from base line at 48th day using SSQOL(stroke specific quqlity of life scale) Blood investigation of Changes vitamin B12Timepoint: 6 Months	—

Countries

India

Contacts

Public ContactC Vijayalakshmi

National Institute Of Siddha

drlakshmiramaswamy@gmail.com9444466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026